316 related articles for article (PubMed ID: 24635348)
1. Use of self-controlled designs in pharmacoepidemiology.
Hallas J; Pottegård A
J Intern Med; 2014 Jun; 275(6):581-9. PubMed ID: 24635348
[TBL] [Abstract][Full Text] [Related]
2. When should case-only designs be used for safety monitoring of medical products?
Maclure M; Fireman B; Nelson JC; Hua W; Shoaibi A; Paredes A; Madigan D
Pharmacoepidemiol Drug Saf; 2012 Jan; 21 Suppl 1():50-61. PubMed ID: 22262593
[TBL] [Abstract][Full Text] [Related]
3. Use of the self-controlled case-series method in vaccine safety studies: review and recommendations for best practice.
Weldeselassie YG; Whitaker HJ; Farrington CP
Epidemiol Infect; 2011 Dec; 139(12):1805-17. PubMed ID: 21849099
[TBL] [Abstract][Full Text] [Related]
4. Methods in epidemiology: observational study designs.
DiPietro NA
Pharmacotherapy; 2010 Oct; 30(10):973-84. PubMed ID: 20874034
[TBL] [Abstract][Full Text] [Related]
5. Self-controlled designs in pharmacoepidemiology involving electronic healthcare databases: a systematic review.
Gault N; Castañeda-Sanabria J; De Rycke Y; Guillo S; Foulon S; Tubach F
BMC Med Res Methodol; 2017 Feb; 17(1):25. PubMed ID: 28178924
[TBL] [Abstract][Full Text] [Related]
6. Challenges and opportunities for pharmacoepidemiology in drug-therapy decision making.
Etminan M; Gill S; Fitzgerald M; Samii A
J Clin Pharmacol; 2006 Jan; 46(1):6-9. PubMed ID: 16397278
[TBL] [Abstract][Full Text] [Related]
7. Underuse of self-controlled designs in pharmacoepidemiology in electronic healthcare databases: a systematic review.
Gault N; Castañeda-Sanabria J; Guillo S; Foulon S; Tubach F
Pharmacoepidemiol Drug Saf; 2016 Apr; 25(4):372-7. PubMed ID: 26781227
[TBL] [Abstract][Full Text] [Related]
8. A comparison of estimators from self-controlled case series, case-crossover design, and sequence symmetry analysis for pharmacoepidemiological studies.
Takeuchi Y; Shinozaki T; Matsuyama Y
BMC Med Res Methodol; 2018 Jan; 18(1):4. PubMed ID: 29310575
[TBL] [Abstract][Full Text] [Related]
9. Unmeasured confounding in pharmacoepidemiology.
Groenwold RH; de Groot MC; Ramamoorthy D; Souverein PC; Klungel OH
Ann Epidemiol; 2016 Jan; 26(1):85-6. PubMed ID: 26559329
[No Abstract] [Full Text] [Related]
10. The case-crossover study design in pharmacoepidemiology.
Delaney JA; Suissa S
Stat Methods Med Res; 2009 Feb; 18(1):53-65. PubMed ID: 18765504
[TBL] [Abstract][Full Text] [Related]
11. Performance of instrumental variable methods in cohort and nested case-control studies: a simulation study.
Uddin MJ; Groenwold RH; de Boer A; Belitser SV; Roes KC; Hoes AW; Klungel OH
Pharmacoepidemiol Drug Saf; 2014 Feb; 23(2):165-77. PubMed ID: 24306965
[TBL] [Abstract][Full Text] [Related]
12. A systematic review on the application of pharmacoepidemiology in assessing prescription drug-related adverse events in pediatrics.
Luo X; Cappelleri JC; Frush K
Curr Med Res Opin; 2007 May; 23(5):1015-24. PubMed ID: 17526119
[TBL] [Abstract][Full Text] [Related]
13. 'Why me?' versus 'why now?'--differences between operational hypotheses in case-control versus case-crossover studies.
Maclure M
Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):850-3. PubMed ID: 17636552
[No Abstract] [Full Text] [Related]
14. Optimal matching ratios in drug safety surveillance.
Wang SV; Schneeweiss S; Rassen JA
Epidemiology; 2014 Sep; 25(5):772-3. PubMed ID: 25076153
[No Abstract] [Full Text] [Related]
15. Methods to control for unmeasured confounding in pharmacoepidemiology: an overview.
Uddin MJ; Groenwold RH; Ali MS; de Boer A; Roes KC; Chowdhury MA; Klungel OH
Int J Clin Pharm; 2016 Jun; 38(3):714-23. PubMed ID: 27091131
[TBL] [Abstract][Full Text] [Related]
16. Approaches to combat with confounding by indication in observational studies of intended drug effects.
McMahon AD
Pharmacoepidemiol Drug Saf; 2003; 12(7):551-8. PubMed ID: 14558178
[TBL] [Abstract][Full Text] [Related]
17. Pharmacoepidemiology I: a review of pharmacoepidemiologic study designs.
Etminan M; Samii A
Pharmacotherapy; 2004 Aug; 24(8):964-9. PubMed ID: 15338844
[TBL] [Abstract][Full Text] [Related]
18. Control yourself: ISPE-endorsed guidance in the application of self-controlled study designs in pharmacoepidemiology.
Cadarette SM; Maclure M; Delaney JAC; Whitaker HJ; Hayes KN; Wang SV; Tadrous M; Gagne JJ; Consiglio GP; Hallas J
Pharmacoepidemiol Drug Saf; 2021 Jun; 30(6):671-684. PubMed ID: 33715267
[TBL] [Abstract][Full Text] [Related]
19. [Interpretation of epidemiologic studies. Type of study, elements of bias, causality].
Touzet S; Colin C
Rev Prat; 1999 Oct; 49(16):1797-804. PubMed ID: 10578612
[No Abstract] [Full Text] [Related]
20. The case-crossover and case-time-control designs in pharmacoepidemiology.
Donnan PT; Wang J
Pharmacoepidemiol Drug Saf; 2001 May; 10(3):259-62. PubMed ID: 11501340
[No Abstract] [Full Text] [Related]
[Next] [New Search]
